Prevalence of genes encoding extracellular proteases in Staphylococcus aureus - important targets triggering immune response in vivo

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 2, 2012, Pages 220-229

  Zdzalik, Michal ^a   Karim, Abdulkarim Y ^a,b   Wolski, Krzysztof ^a   Buda, Pawel ^a   Wojcik, Kinga ^a   Brueggemann, Sarah ^a   Wojciechowski, Piotr ^a   Eick, Sigrun ^c   Calander, Ann Marie ^d   Jonsson, Ing Marie ^d   Kubica, Malgorzata ^a   Polakowska, Klaudia ^a   Miedzobrodzki, Jacek ^a   Wladyka, Benedykt ^a   Potempa, Jan ^a   Dubin, Grzegorz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b SALAHADDIN UNIVERSITY   (Iraq)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antistaphylococcal immune response; Extracellular staphylococcal proteases; Sernine protease like proteins; Staphylococcal virulence factors; Staphylococcus aureus

Indexed keywords

AUREOLYSIN; PROTEINASE; STAPHOPAIN A; STAPHOPAIN B; UNCLASSIFIED DRUG; V8 PROTEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; PROTEASE GENE; PROTEIN TARGETING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; FEMALE; GENOME, BACTERIAL; HUMANS; MICE; PEPTIDE HYDROLASES; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84867691470     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.01005.x     Document Type: Article

References (40)

1. Abdel-Haq N, Al-Tatari H, Chearskul P, Salimnia H, Asmar BI, Fairfax MR & Amjad M (2009) Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized children: correlation of molecular analysis with clinical presentation and antibiotic susceptibility testing (ABST) results. Eur J Clin Microbiol Infect Dis 28: 547-551.
2. Arvidson S (1973) Studies on extracellular proteolytic enzymes from Staphylococcus aureus. II. Isolation and characterization of an EDTA-sensitive protease. Biochim Biophys Acta 302: 149-157.
3. Arvidson S, Holme T & Lindholm B (1973) Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease. Biochim Biophys Acta 302: 135-148.
4. Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G & Von Eiff C (2003) Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol 41: 1434-1439.
5. Bukowski M, Wladyka B & Dubin G (2010) Exfoliative Toxins of Staphylococcus aureus. Toxins 2: 1148-1165.
6. Calander AM, Jonsson IM, Kanth A, Arvidsson S, Shaw L, Foster SJ & Tarkowski A (2004) Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect 6: 202-206.
7. Clayton EM, Rea MC, Shanahan F, Quigley EM, Kiely B, Hill C & Ross RP (2009) The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 104: 1162-1169.
8. Coulter SN, Schwan WR, Ng EY, Langhorne MH, Ritchie HD, Westbrock-Wadman S, Hufnagle WO, Folger KR, Bayer AS & Stover CK (1998) Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol 30: 393-404.
9. Drapeau GR, Boily Y & Houmard J (1972) Purification and properties of an extracellular protease of Staphylococcus aureus. J Biol Chem 247: 6720-6726.
10. Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, Kustos T, Henics T, Meinke A & Nagy E (2005) Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol 12: 387-398.
11. Dubin G (2002) Extracellular proteases of Staphylococcus spp. Biol Chem 383: 1075-1086.
12. Dubin G, Stec-Niemczyk J, Kisielewska M et al. (2008) Enzymatic activity of the Staphylococcus aureus SplB serine protease is induced by substrates containing the sequence Trp-Glu-Leu-Gln. J Mol Biol 379: 343-356.
13. Elias PM, Mittermayer H, Tappeiner G, Fritsch P & Wolff K (1974) Staphylococcal toxic epidermal necrolysis (TEN): the expanded mouse model. J Invest Dermatol 63: 467-475.
14. Fritsch PO, Kaaserer G & Elias PM (1979) Action of staphylococcal epidermolysin: further observations on its species specificity. Arch Dermatol Res 264: 287-291.
15. Gemmell CG (1995) Staphylococcal scalded skin syndrome. J Med Microbiol 43: 318-327.
16. Golonka E, Filipek R, Sabat A, Sinczak A & Potempa J (2004) Genetic characterization of staphopain genes in Staphylococcus aureus. Biol Chem 385: 1059-1067.
17. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D & Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41: 5442-5448.
18. Kapral FA & Miller MM (1971) Product of Staphylococcus aureus responsible for the scalded-skin syndrome. Infect Immun 4: 541-545.
19. Karlsson A & Arvidson S (2002) Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect Immun 70: 4239-4246.
20. Khambaty FM, Bennett RW & Shah DB (1994) Application of pulsed-field gel electrophoresis to the epidemiological characterization of Staphylococcus intermedius implicated in a food-related outbreak. Epidemiol Infect 113: 75-81.
21. Le J & Lieberman JM (2006) Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy 26: 1758-1770.
22. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
23. Melish ME & Glasgow LA (1970) The staphylococcal scalded-skin syndrome. N Engl J Med 282: 1114-1119.
24. Miyata E, Satoh S, Inokuchi K et al. (2007) Three fatal cases of rapidly progressive infective endocarditis caused by Staphylococcus aureus: one case with huge vegetation. Circ J 71: 1488-1491.
25. Morin CA, Hadler JL (2001) Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 184: 1029-1034.
26. Nishifuji K, Sugai M & Amagai M (2008) Staphylococcal exfoliative toxins: 'molecular scissors' of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 49: 21-31.
27. Plano LR, Adkins B, Woischnik M, Ewing R & Collins CM (2001) Toxin levels in serum correlate with the development of staphylococcal scalded skin syndrome in a murine model. Infect Immun 69: 5193-5197.
28. Popowicz GM, Dubin G, Stec-Niemczyk J, Czarny A, Dubin A, Potempa J & Holak TA (2006) Functional and structural characterization of Spl proteases from Staphylococcus aureus. J Mol Biol 358: 270-279.
29. Reed SB, Wesson CA, Liou LE, Trumble WR, Schlievert PM, Bohach GA & Bayles KW (2001) Molecular characterization of a novel Staphylococcus aureus serine protease operon. Infect Immun 69: 1521-1527.
30. Rieneck K, Renneberg J, Diamant M, Gutschik E & Bendtzen K (1997) Molecular cloning and expression of a novel Staphylococcus aureus antigen. Biochim Biophys Acta 1350: 128-132.
31. Sabat AJ, Wladyka B, Kosowska-Shick K, Grundmann H, van Dijl JM, Kowal J, Appelbaum PC, Dubin A & Hryniewicz W (2008) Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureus strains. BMC Microbiol 8: 129.
32. Schito GC (2006) The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect 12(Suppl 1): 3-8.
33. Schwan WR, Langhorne MH, Ritchie HD & Stover CK (2003) Loss of hemolysin expression in Staphylococcus aureus agr mutants correlates with selective survival during mixed infections in murine abscesses and wounds. FEMS Immunol Med Microbiol 38: 23-28.
34. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, Bost DA, Riehman M, Naidich S & Kreiswirth BN (1999) Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 37: 3556-3563.
35. Sifri CD, Begun J, Ausubel FM & Calderwood SB (2003) Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect Immun 71: 2208-2217.
36. Stec-Niemczyk J, Pustelny K, Kisielewska M et al. (2009) Structural and functional characterization of SplA, an exclusively specific protease of Staphylococcus aureus. Biochem J 419: 555-564.
37. Stevens MP & Edmond MB (2009) The rising tide: skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus. South Med J 102: 121-122.
38. Sudagidan M, Cavusoglu C & Bacakoglu F (2008) Investigation of the virulence genes in methicillin-resistant Staphylococcus aureus strains isolated from biomaterial surfaces. Mikrobiyol Bul 42: 29-39.
39. Takeuchi S, Saito M, Imaizumi K, Kaidoh T, Higuchi H & Inubushi S (2002) Genetic and enzymatic analyses of metalloprotease (aureolysin) from Staphylococcus aureus isolated from domestic animals. Vet Microbiol 84: 135-142.
40. Wibawan IW & Lammler C (1992) Relationship between group B streptococcal serotypes and cell surface hydrophobicity. Zentralbl Veterinarmed B 39: 376-382.